Physician profile
Robert W Secor
NPI 1861494478
$5,460.42
in general payments reported to CMS, 2019-2025
43 companies · $810 in 2025
The $810 reported for 2025 was more than what 82% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,899 · 2020: $448 · 2021: $520 · 2022: $502 · 2023: $534 · 2024: $747 · 2025: $810.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,091.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,091.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $781.24 | 2019-2025 | Farxiga, Airsupra, Andexxa |
| Novo Nordisk INC | $695.31 | 2019-2025 | Wegovy, Ozempic, Rybelsus |
| Abbvie INC. | $552.25 | 2019-2025 | Ubrelvy, Qulipta, Vraylar |
| Amgen INC. | $427.63 | 2019-2025 | Evenity, Prolia, Otezla |
| Merck Sharp & Dohme LLC | $374.97 | 2019-2025 | Gardasil 9, Keytruda, Gardasil |
| Pfizer INC. | $346.60 | 2019-2025 | |
| Glaxosmithkline, LLC. | $263.29 | 2019-2025 | Shingrix, Arexvy, Trelegy Ellipta |
| Lilly USA, LLC | $194.12 | 2019-2023 | Mounjaro, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $181.50 | 2022-2025 | |
| Allergan, INC. | $171.60 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $139.64 | 2019-2024 | Xifaxan |
| Boston Scientific Corporation | $120.86 | 2025 | Watchman Access System |
| Takeda Pharmaceuticals U.S.A., INC. | $91.24 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $88.69 | 2019-2024 | |
| Kowa Pharmaceuticals America, INC. | $85.11 | 2019-2021 |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Secor listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.